A significant advance in cancer investigation is emerging with the use of nanobodies to reactivate mutated p53. This crucial tumor suppressor protein is frequently disabled in several forms of cancer, resulting https://socialmediaentry.com/story7468738/mini-antibodies-reactivate-tumor-suppressor-p53-a-promising-approach-for-cancer-therapy